We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+18.38%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.71B
AUM Growth
-$281M
Cap. Flow
-$830M
Cap. Flow %
-22.37%
Top 10 Hldgs %
31.98%
Holding
127
New
29
Increased
29
Reduced
22
Closed
37

Top Buys

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$73.3M
2
MCK icon
McKesson
MCK
+$66.4M
3
NOW icon
ServiceNow
NOW
+$60.6M
4
DXC icon
DXC Technology
DXC
+$60M
5
MSFT icon
Microsoft
MSFT
+$58M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$125M
2
MRVL icon
Marvell Technology
MRVL
+$118M
3
BIIB icon
Biogen
BIIB
+$102M
4
WFT
Weatherford International plc
WFT
+$102M
5
CSC
Computer Sciences
CSC
+$98M

Sector Composition

Rank Sector Weight
1 Healthcare 40.08%
2 Technology 13.76%
3 Consumer Discretionary 5.54%
4 Communication Services 4.09%
5 Financials 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
101
SLB Ltd
SLB
$77.8B
– –
-549,389
Closed -$42.9M
STX icon
102
Seagate
STX
$193B
– –
-232,051
Closed -$10.7M
TEX icon
103
Terex
TEX
$7.98B
– –
-175,632
Closed -$5.51M
UNP icon
104
Union Pacific
UNP
$183B
– –
-299,502
Closed -$31.7M
WERN icon
105
Werner Enterprises
WERN
$2.54B
– –
-378,393
Closed -$9.91M
XNTK icon
106
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
– –
-1,114,600
Closed -$77.3M
ZION icon
107
Zions Bancorporation
ZION
$10.1B
– –
-501,992
Closed -$21.1M
PDCO
108
DELISTED
Patterson Companies, Inc.
PDCO
– –
-635,863
Closed -$28.8M
NVRO
109
DELISTED
NEVRO CORP.
NVRO
– –
-116,836
Closed -$10.9M
SLCA
110
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
– –
-1,350,636
Closed -$64.8M
SPLK
111
DELISTED
Splunk Inc
SPLK
– –
-682,657
Closed -$42.5M
AKRX
112
DELISTED
Akorn Inc
AKRX
– –
-1,817,174
Closed -$43.8M
WFT
113
DELISTED
Weatherford International plc
WFT
– –
-15,289,479
Closed -$102M
TFCFA
114
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
– –
-1,663,321
Closed -$53.9M
ATHN
115
DELISTED
Athenahealth, Inc.
ATHN
– –
-342,540
Closed -$38.6M
ANDV
116
DELISTED
Andeavor
ANDV
– –
-460,878
Closed -$37.4M
AVXS
117
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-70,170
Closed -$5.33M
ZLTQ
118
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-2,062
Closed -$115K
CSC
119
DELISTED
Computer Sciences
CSC
– –
-1,420,281
Closed -$98M
1 2 3 4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2017 Portfolio in Review

As of Q2 2017, PFM Health Sciences held 127 positions worth $3.71B, down 7% from $3.99B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences withdrew a net $830M in Q2 2017, closing 37 positions and reducing 22 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PFM Health Sciences opened a new position in McKesson worth $72.1M.

  • PFM Health Sciences's largest Q2 2017 buy was McKesson: 438,055 shares worth $72.1M.
  • PFM Health Sciences added most to Kite Pharma, Inc. in Q2 2017, an estimated $73.3M increase.
  • PFM Health Sciences's biggest Q2 2017 reduction was Marvell Technology, cutting an estimated $118M.
  • PFM Health Sciences fully exited Jazz Pharmaceuticals in Q2 2017, selling an estimated $125M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.71B portfolio in Q2 2017.
  • PFM Health Sciences opened 29 new positions and closed 37 in Q2 2017.
  • PFM Health Sciences's portfolio value fell 7% quarter-over-quarter to $3.71B.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.